Pharma companies are leveraging the United States’ threat of tariffs on drug imports to push for policy changes in the EU. | ...

Any retaliation from the European Union to tariffs introduced by the United States should avoid dragging the pharmaceutical ...

European pharma companies warned the European Commission president at a meeting on Tuesday that U.S. tariffs would expedite ...

The possibility of tariffs on pharmaceutical imports has been floated multiple ... A 20% import tariff on EU medical devices ...

Although President Donald Trump’s “Liberation Day” tariffs have spared pharmaceuticals, potential drug-specific import taxes ...

The EU executive and top pharmaceutical companies shared a video call to address concerns over potential US tariffs on drugs ...

Tanaiste Simon Harris has said it would be “bizarre” for the United States to impose new tariffs on EU pharmaceutical exports ...

Nearly three dozen global pharmaceutical companies, including Pfizer and AstraZeneca, urged the European Commission to support them against threatened U.S. tariffs. Concerns include higher costs ...

Tánaiste Simon Harris has said any future tariff negotiations between the EU and the US should include the pharmaceutical ...

The US president vows "major" tariffs on imported medicines - raising fears of an increase in costs for Americans.

Mid-sized Indian pharma firms revamp strategies amid US tariff concerns, focusing on NCDs, API manufacturing, emerging ...

The exemption may be short-lived if President Trump makes good on threats to use tariffs as leverage to bring drug production ...